APA

First M. R., Weiskittel P., Burton M. L., Shah M. B., Dreyer D., Fleck P., Bey C., Peddi V. R., Canafax D. M. & Schroeder T. J. (19990415). Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. : Transplantation proceedings.

Chicago

First M R, Weiskittel P, Burton M L, Shah M B, Dreyer D, Fleck P, Bey C, Peddi V R, Canafax D M and Schroeder T J. 19990415. Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. : Transplantation proceedings.

Harvard

First M. R., Weiskittel P., Burton M. L., Shah M. B., Dreyer D., Fleck P., Bey C., Peddi V. R., Canafax D. M. and Schroeder T. J. (19990415). Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. : Transplantation proceedings.

MLA

First M R, Weiskittel P, Burton M L, Shah M B, Dreyer D, Fleck P, Bey C, Peddi V R, Canafax D M and Schroeder T J. Nine-month follow-up of SangCya (Sang-35) in kidney transplant patients after conversion from Sandimmune. : Transplantation proceedings. 19990415.